Phase II Study of Endoscopic Ultrasound Radiofrequency Ablation in Patients with Resectable Pancreatic Cancer (PANCARDINAL-1)
Summary
The purpose of this phase II study is to evaluate the safety, feasibility, and treatment effect of Endoscopic Ultrasound (EUS) Radiofrequency ablation (RFA) plus standard-of-care of Neoadjuvant chemotherapy (NAC) in patients with pancreatic adenocarcinoma.
General Information
NCT#: NCT04990609
Study ID: HSC-MS-21-0066
Trial Phase: Phase II
Trial Sponsor: The University of Texas Health Science Center, Houston
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, FOLFIRINOX